Atrial Fibrillation After Immune Checkpoint Inhibitor Therapy: Incidence, Timing, and Associated Factors - A Systematic Review and Meta-Analysis
Published: 3 August 2026| Version 1 | DOI: 10.17632/g9st2sgb7r.1
Contributor:
Description
This dataset contains the extracted study-level data used for the systematic review and meta-analysis of atrial fibrillation following immune checkpoint inhibitor therapy. Variables include study characteristics, patient demographics, cancer type, immune checkpoint inhibitor regimen, incident atrial fibrillation events, sample size, follow-up, person-time data (where available), and reported risk estimates. The dataset was compiled from eligible published studies identified through a systematic literature search and was used to generate all quantitative analyses reported in the accompanying manuscript.
Files
Institutions
- Icahn School of Medicine at Mount SinaiNew York, New York
Categories
Atrial Fibrillation, Systematic Review with Meta-Analysis, Immune Checkpoint Inhibitor